NCT06617481View on ClinicalTrials.gov

PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence

PHASE2RecruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

September 20, 2024

Primary Completion Date

September 5, 2027

Study Completion Date

October 10, 2027

Conditions

Prostate Cancer (Post Prostatectomy)

Interventions

DRUG

18F-rhPSMA-7.3 (Posluma)

PET Scan using Posluma for detection of early recurrence of prostate cancer.

Trial Locations (1)

32804

RECRUITING

AdventHealth, Orlando

Sponsors

Lead Sponsor

Collaborators (1)

Blue Earth Diagnostics

All Listed Sponsors

collaborator

Blue Earth Diagnostics

INDUSTRY

lead

AdventHealth

OTHER

NCT06617481 - PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence | Biotech Hunter | Biotech Hunter